MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 44 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $715,551 | +32.9% | 22,644 | +8.8% | 0.00% | – |
| Q2 2023 | $538,356 | +188.1% | 20,810 | +167.5% | 0.00% | – |
| Q1 2023 | $186,851 | +31.6% | 7,779 | +6.8% | 0.00% | – |
| Q4 2022 | $141,980 | -7.2% | 7,281 | 0.0% | 0.00% | – |
| Q3 2022 | $153,000 | +19.5% | 7,281 | +10.6% | 0.00% | – |
| Q2 2022 | $128,000 | +2033.3% | 6,583 | +2193.7% | 0.00% | – |
| Q1 2022 | $6,000 | +20.0% | 287 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | -16.7% | 287 | 0.0% | 0.00% | – |
| Q3 2021 | $6,000 | 0.0% | 287 | -18.5% | 0.00% | – |
| Q2 2021 | $6,000 | -40.0% | 352 | -28.7% | 0.00% | – |
| Q1 2021 | $10,000 | +11.1% | 494 | 0.0% | 0.00% | – |
| Q4 2020 | $9,000 | 0.0% | 494 | 0.0% | 0.00% | – |
| Q3 2020 | $9,000 | -43.8% | 494 | -39.6% | 0.00% | – |
| Q2 2020 | $16,000 | +45.5% | 818 | 0.0% | 0.00% | – |
| Q1 2020 | $11,000 | -21.4% | 818 | +48.5% | 0.00% | – |
| Q4 2019 | $14,000 | – | 551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 1,921,118 | $38,269,000 | 6.42% |
| FRAZIER MANAGEMENT LLC | 3,566,912 | $71,053,000 | 5.68% |
| Novo Holdings A/S | 2,445,147 | $48,707,000 | 2.52% |
| Sio Capital Management, LLC | 248,978 | $4,960,000 | 1.58% |
| Mesirow Financial Investment Management, Inc. | 25,795 | $514,000 | 1.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,282,912 | $65,396,000 | 1.28% |
| NEA Management Company, LLC | 4,187,801 | $83,421,000 | 0.99% |
| MPM BioImpact LLC | 308,532 | $6,146,000 | 0.95% |
| Rock Springs Capital Management LP | 1,525,623 | $30,390,000 | 0.64% |
| BVF INC/IL | 435,936 | $8,684,000 | 0.34% |